ÃÖ¿ì¼öÆ÷½ºÅÍ»ó |
|
|
|
2017³âµµ Á¦ 103Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ ÃÖ¿ì¼öÆ÷½ºÅÍ»ó ¼ö»óÀÚ·Î ¼±Á¤µÇ½ÉÀ» Áø½ÉÀ¸·Î ÃàÇϵ帳´Ï´Ù. |
|
¸ðüžÆÀÇÇÐ
|
- ¼º¸í : Á¤¿¬ÁØ
- ¼Ò¼Ó : Áß¾ÓÀÇ´ë
- ³í¹®Á¦¸ñ : ÃÖ¼ÒÇÑÀÇ Áغñ¸¸À¸·Î ¿Ü·¡¿¡¼ ½ÃÇàµÈ °£´ÜÇÑ ¿ÜȸÀü¼ú¿¡ ´ëÇÑ ¿¬±¸
|
|
|
ºÎÀÎÁ¾¾çÇÐ
|
- ¼º¸í : ±è»óÀÏ
- ¼Ò¼Ó : °¡Å縯ÀÇ´ë
- ³í¹®Á¦¸ñ : Biomarker utility of the E2/E6 ratio and L1 immunoreactivity for determining HPV16-positive ¡ÃCIN2 lesions and cervical squamous cell carcinoma
|
|
|
»ý½Ä³»ºÐºñÇÐ
|
- ¼º¸í : Á¤ÀÌÁ¶
- ¼Ò¼Ó : ¿ï»êÀÇ´ë
- ³í¹®Á¦¸ñ : Collagen mixed with epidermal growth factor promotes the endometrial HOXA10 expression as well as endometrial growth in patients with thin endometrium
|
|
|
ÀϹݺÎÀΰúÇÐ
|
- ¼º¸í : ¹®Á¾È£
- ¼Ò¼Ó : Àü³²ÀÇ´ë
- ³í¹®Á¦¸ñ : Factors associated with recurrence after colpocleisis for pelvic organ prolapse in elderly women
|
|